Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine
US-12582634-B2 · Mar 24, 2026 · US
Neurocrine Biosciences Inc holds 152 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 152 |
| Recent patents | 35 |
| First publication | Jan 15, 2015 |
| Latest publication | Mar 24, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12582634-B2 · Mar 24, 2026 · US
US-2026048042-A1 · Feb 19, 2026 · US
US-12486250-B2 · Dec 2, 2025 · US
US-2025333413-A1 · Oct 30, 2025 · US
US-2025333404-A1 · Oct 30, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12582634-B2 · Mar 24, 2026 · US
US-2026048042-A1 · Feb 19, 2026 · US
US-12486250-B2 · Dec 2, 2025 · US
US-2025333413-A1 · Oct 30, 2025 · US
US-2025333404-A1 · Oct 30, 2025 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 142 |
| Chemistry & Metallurgy | 104 |
| Physics | 7 |
| Cross-Sectional Technologies | 1 |
Answers are generated from the same data shown on this page.